In Brief: Nicox Extends Cash Runway As Kowa Advances NCX 470 In Japan

H2 Start For Phase III Trial

 
• By Sushmita Panda
  
Asia ophthalmology
Kowa advances Nicox's ocular hypertension candidate in Japan (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from Therapy Areas